These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23779109)

  • 1. Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates.
    Stawikowska R; Cudic M; Giulianotti M; Houghten RA; Fields GB; Minond D
    J Biol Chem; 2013 Aug; 288(31):22871-9. PubMed ID: 23779109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates.
    Minond D; Cudic M; Bionda N; Giulianotti M; Maida L; Houghten RA; Fields GB
    J Biol Chem; 2012 Oct; 287(43):36473-87. PubMed ID: 22927435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation of a disintegrin and metalloprotease 17 affects its activity and inhibition.
    Chavaroche A; Cudic M; Giulianotti M; Houghten RA; Fields GB; Minond D
    Anal Biochem; 2014 Mar; 449():68-75. PubMed ID: 24361716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.
    Knapinska AM; Dreymuller D; Ludwig A; Smith L; Golubkov V; Sohail A; Fridman R; Giulianotti M; LaVoi TM; Houghten RA; Fields GB; Minond D
    J Med Chem; 2015 Aug; 58(15):5808-24. PubMed ID: 26192023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate conformation modulates aggrecanase (ADAMTS-4) affinity and sequence specificity. Suggestion of a common topological specificity for functionally diverse proteases.
    Lauer-Fields JL; Minond D; Sritharan T; Kashiwagi M; Nagase H; Fields GB
    J Biol Chem; 2007 Jan; 282(1):142-50. PubMed ID: 17095512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico and Experimental ADAM17 Kinetic Modeling as Basis for Future Screening System for Modulators.
    Bienstein M; Minond D; Schwaneberg U; Davari MD; Yildiz D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10.
    Caescu CI; Jeschke GR; Turk BE
    Biochem J; 2009 Oct; 424(1):79-88. PubMed ID: 19715556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate.
    Madoux F; Dreymuller D; Pettiloud JP; Santos R; Becker-Pauly C; Ludwig A; Fields GB; Bannister T; Spicer TP; Cudic M; Scampavia LD; Minond D
    Sci Rep; 2016 Dec; 6(1):11. PubMed ID: 28442704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rearranging exosites in noncatalytic domains can redirect the substrate specificity of ADAMTS proteases.
    Gao W; Zhu J; Westfield LA; Tuley EA; Anderson PJ; Sadler JE
    J Biol Chem; 2012 Aug; 287(32):26944-52. PubMed ID: 22707719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A disintegrin and metalloprotease 17 dynamic interaction sequence, the sweet tooth for the human interleukin 6 receptor.
    Düsterhöft S; Höbel K; Oldefest M; Lokau J; Waetzig GH; Chalaris A; Garbers C; Scheller J; Rose-John S; Lorenzen I; Grötzinger J
    J Biol Chem; 2014 Jun; 289(23):16336-48. PubMed ID: 24790088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor α ectodomain shedding.
    Schwarz J; Schmidt S; Will O; Koudelka T; Köhler K; Boss M; Rabe B; Tholey A; Scheller J; Schmidt-Arras D; Schwake M; Rose-John S; Chalaris A
    J Biol Chem; 2014 Jan; 289(5):3080-93. PubMed ID: 24338472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of pro-tumor necrosis factor alpha by ADAM metallopeptidase domain 17: a fluorescence-based protease assay cleaves its natural protein substrate.
    Zhang C; Zheng L; Nurnberg J; Vacari BM; Zhou J; Wang Y
    Anal Biochem; 2014 Jan; 445():14-9. PubMed ID: 24096196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries.
    Tucher J; Linke D; Koudelka T; Cassidy L; Tredup C; Wichert R; Pietrzik C; Becker-Pauly C; Tholey A
    J Proteome Res; 2014 Apr; 13(4):2205-14. PubMed ID: 24635658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meprin β induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage.
    Wichert R; Scharfenberg F; Colmorgen C; Koudelka T; Schwarz J; Wetzel S; Potempa B; Potempa J; Bartsch JW; Sagi I; Tholey A; Saftig P; Rose-John S; Becker-Pauly C
    FASEB J; 2019 Nov; 33(11):11925-11940. PubMed ID: 31381863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM proteases: Emerging role and targeting of the non-catalytic domains.
    Saha N; Robev D; Himanen JP; Nikolov DB
    Cancer Lett; 2019 Dec; 467():50-57. PubMed ID: 31593799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.
    Bozkulak EC; Weinmaster G
    Mol Cell Biol; 2009 Nov; 29(21):5679-95. PubMed ID: 19704010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Juxtamembrane Segment of ADAM17 Interacts with Membranes and Is Essential for Its Shedding Activity.
    Düsterhöft S; Michalek M; Kordowski F; Oldefest M; Sommer A; Röseler J; Reiss K; Grötzinger J; Lorenzen I
    Biochemistry; 2015 Sep; 54(38):5791-801. PubMed ID: 26348730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytically active ADAM10 and ADAM17 carried on membrane microvesicles in human abdominal aortic aneurysms.
    Folkesson M; Li C; Frebelius S; Swedenborg J; Wågsäter D; Williams KJ; Eriksson P; Roy J; Liu ML
    Thromb Haemost; 2015 Nov; 114(6):1165-74. PubMed ID: 26422658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel interaction between ADAM17 (a disintegrin and metalloprotease 17) and thioredoxin-1.
    Aragão AZ; Nogueira ML; Granato DC; Simabuco FM; Honorato RV; Hoffman Z; Yokoo S; Laurindo FR; Squina FM; Zeri AC; Oliveira PS; Sherman NE; Paes Leme AF
    J Biol Chem; 2012 Dec; 287(51):43071-82. PubMed ID: 23105116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble T cell immunoglobulin and mucin domain (TIM)-1 and -4 generated by A Disintegrin And Metalloprotease (ADAM)-10 and -17 bind to phosphatidylserine.
    Schweigert O; Dewitz C; Möller-Hackbarth K; Trad A; Garbers C; Rose-John S; Scheller J
    Biochim Biophys Acta; 2014 Feb; 1843(2):275-87. PubMed ID: 24286866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.